Oncodesign
3 SlideShares
Personal Information
Entreprise/Lieu de travail
Dijon Cedex, NA France
Secteur d’activité
Chemicals
Site Web
www.oncodesign.com
À propos
Oncodesign, vector of innovation, is a biopharma whose mission is to discover new therapies in precision medicine. To do this, Oncodesign has developed a unique model of patient-centered innovation using proprietary technologies. Oncodesign offers outstanding expertise combining medicinal chemistry, pharmacology, regulatory bioanalysis and advanced medical imaging. We are able to predict and identify, far upstream, for each molecule its therapeutic utility and its potential to become an effective drug, both in oncology and in our new therapeutic areas such as inflammation and inflammation. immunology. This expertise is available through 3 offers: services, partnership and licensing.
Coordonnées
Mots-clés
adme biochemical assay drug discovery medicinal chemistry kinase inhibitor macrocycles therapeutic response monitoring ngs genomic monitoring clinical monitoring pancreatic cancer breast cancer lung cancer cancer treatment patient resistant ai artificial intelligence macrocyclization nanocyclix immunogenic cell death icd n-sulfoglucosamine sulfohydrolase (sgsh) mucopolysaccharidosis type iiia (mps iiia)
Tout plus
Personal Information
Entreprise/Lieu de travail
Dijon Cedex, NA France
Secteur d’activité
Chemicals
Site Web
www.oncodesign.com
À propos
Oncodesign, vector of innovation, is a biopharma whose mission is to discover new therapies in precision medicine. To do this, Oncodesign has developed a unique model of patient-centered innovation using proprietary technologies. Oncodesign offers outstanding expertise combining medicinal chemistry, pharmacology, regulatory bioanalysis and advanced medical imaging. We are able to predict and identify, far upstream, for each molecule its therapeutic utility and its potential to become an effective drug, both in oncology and in our new therapeutic areas such as inflammation and inflammation. immunology. This expertise is available through 3 offers: services, partnership and licensing.
Mots-clés
adme biochemical assay drug discovery medicinal chemistry kinase inhibitor macrocycles therapeutic response monitoring ngs genomic monitoring clinical monitoring pancreatic cancer breast cancer lung cancer cancer treatment patient resistant ai artificial intelligence macrocyclization nanocyclix immunogenic cell death icd n-sulfoglucosamine sulfohydrolase (sgsh) mucopolysaccharidosis type iiia (mps iiia)
Tout plus